Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
GILD
|
John Francis Cogan
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,413 Added 4.04% |
$47,367
$19.63 p/Share
|
Apr 06
2020 |
|
REGN
|
Robert E Landry
EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,304 Reduced 8.42% |
$1,151,884
$499.95 p/Share
|
Apr 06
2020 |
|
REGN
|
Robert E Landry
EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 3,000 Added 9.88% |
$818,100
$272.7 p/Share
|
Apr 06
2020 |
|
TELA
|
Ew Healthcare Partners Fund 2, L.P. |
BUY
Open market or private purchase
|
Indirect | 17,866 Added 0.0% |
$144,714
$8.1 p/Share
|
Apr 06
2020 |
|
ESQ
|
Kevin C Waterhouse
Director |
BUY
Open market or private purchase
|
Indirect | 1,000 Added 2.04% |
$14,600
$14.6 p/Share
|
Apr 06
2020 |
|
AMCR
|
Nicholas T. Long |
BUY
Open market or private purchase
|
Indirect | 240 Added 5.28% |
$1,968
$8.2 p/Share
|
Apr 06
2020 |
|
NSC
|
Alan H. Shaw |
BUY
Open market or private purchase
|
Indirect | 4 Added 7.27% |
$614
$153.57 p/Share
|
Apr 06
2020 |
|
GAXY
|
Magen Mc Gahee
CFO |
BUY
Open market or private purchase
|
Direct | 42,000 Added 2.34% |
$420
$0.01 p/Share
|
Apr 06
2020 |
|
COGT
|
Dario Campana
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 50,080 Reduced 0.98% |
$17,528
$0.35 p/Share
|
Apr 06
2020 |
|
ABBV
|
Henry O Gosebruch
EVP, Chief Strategy Officer |
BUY
Bona fide gift
|
Indirect | 18,500 Added 27.61% |
-
|
Apr 06
2020 |
|
ABBV
|
Henry O Gosebruch
EVP, Chief Strategy Officer |
SELL
Bona fide gift
|
Direct | 18,500 Reduced 23.57% |
-
|
Apr 06
2020 |
|
MDIA
|
Standard General L.P. |
BUY
Small Acquisition
|
Indirect | 1,469 Added 1.29% |
$5,171
$3.52 p/Share
|
Apr 06
2020 |
|
MCHX
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect | 25,800 Added 0.4% |
$90,300
$3.5 p/Share
|
Apr 06
2020 |
|
MCHX
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect | 4,200 Added 0.44% |
$14,700
$3.5 p/Share
|
Apr 06
2020 |
|
AYTU
|
Armistice Capital, LLC
Director |
BUY
Other acquisition or disposition
|
Indirect | 0 Added 0.0% |
-
|
Apr 06
2020 |
|
AYTU
|
Armistice Capital, LLC
Director |
BUY
Other acquisition or disposition
|
Direct | 108,920 Added 50.0% |
-
|
Apr 06
2020 |
|
CRWD
|
Warburg Pincus Private Equity X, L.P.
Director |
BUY
Conversion of derivative security
|
Indirect | 310,000 Added 50.0% |
-
|
Apr 06
2020 |
|
CRWD
|
Warburg Pincus Private Equity X, L.P.
Director |
SELL
Open market or private sale
|
Indirect | 310,000 Reduced 100.0% |
$17,828,099
$57.51 p/Share
|
Apr 06
2020 |
|
CRWD
|
Warburg Pincus Private Equity X, L.P.
Director |
BUY
Conversion of derivative security
|
Direct | 9,690,000 Added 50.0% |
-
|
Apr 06
2020 |
|
CRWD
|
Warburg Pincus Private Equity X, L.P.
Director |
SELL
Open market or private sale
|
Direct | 9,690,000 Reduced 100.0% |
$557,271,884
$57.51 p/Share
|
Apr 06
2020 |
|
NVDA
|
Mark A Stevens
Director |
SELL
Open market or private sale
|
Indirect | 60,000 Reduced 1.73% |
$15,697,800
$261.63 p/Share
|
Apr 06
2020 |
|
PEN
|
Bridget O'Rourke
Director |
SELL
Open market or private sale
|
Direct | 44 Reduced 1.2% |
$7,153
$162.56 p/Share
|
Apr 06
2020 |
|
HZNP
|
Brian K Beeler
EVP, General Counsel |
SELL
Open market or private sale
|
Direct | 2,370 Reduced 2.1% |
$77,025
$32.5 p/Share
|
Apr 06
2020 |
|
QMCO
|
B. Riley Financial, Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 100,000 Added 1.22% |
$270,000
$2.7 p/Share
|
Apr 06
2020 |
|
SPLP
|
Gordon A. Walker
Senior Vice President |
BUY
Open market or private purchase
|
Direct | 3,285 Added 17.82% |
$16,688
$5.08 p/Share
|
Apr 06
2020 |
|
TPTX
|
Jingrong Jean Cui
Director |
SELL
Open market or private sale
|
Indirect | 18,500 Reduced 0.48% |
$803,455
$43.43 p/Share
|
Apr 06
2020 |
|
MRNA
|
Juan Andres
Officer |
SELL
Open market or private sale
|
Direct | 300 Reduced 100.0% |
$10,539
$35.13 p/Share
|
Apr 06
2020 |
|
MRNA
|
Juan Andres
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 300 Added 50.0% |
$3,663
$12.21 p/Share
|
Apr 06
2020 |
|
NEM
|
John Kitlen
VP, Controller & CAO |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 3.47% |
$72,645
$48.43 p/Share
|
Apr 06
2020 |
|
NEM
|
Dean Gehring
EVP, Chief Dev Officer-Peru |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 14.14% |
$193,720
$48.43 p/Share
|
Apr 06
2020 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1 Added 0.0% |
$475
$475.03 p/Share
|
Apr 06
2020 |
|
LLY
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct | 15,962 Reduced 0.01% |
$2,278,256
$142.73 p/Share
|
Apr 06
2020 |
|
EA
|
Chris Bruzzo
Chief Experience Officer |
SELL
Open market or private sale
|
Direct | 700 Reduced 3.22% |
$73,773
$105.39 p/Share
|
Apr 06
2020 |
|
SREV
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 12,800 Added 0.13% |
$10,880
$0.85 p/Share
|
Apr 06
2020 |
|
MACK
|
Noah G. Levy
Director |
BUY
Open market or private purchase
|
Indirect | 6,042 Added 0.5% |
$18,126
$3.0 p/Share
|
Apr 06
2020 |
|
MACK
|
Eric Andersen |
BUY
Open market or private purchase
|
Indirect | 6,043 Added 0.88% |
$18,129
$3.0 p/Share
|
Apr 06
2020 |
|
SPWR
|
Total S.A.
Director |
BUY
Open market or private purchase
|
Indirect | 205,000 Added 0.24% |
$1,104,950
$5.39 p/Share
|
Apr 06
2020 |
|
GOOG
|
John L Hennessy |
SELL
Open market or private sale
|
Indirect | 45 Reduced 2.07% |
$51,961
$1154.69 p/Share
|
Apr 06
2020 |
|
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 0.03% |
$1,435,000
$143.5 p/Share
|
Apr 06
2020 |
|
CRM
|
Marc Benioff
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 0.03% |
$523,000
$52.3 p/Share
|
Apr 06
2020 |
|
FEIM
|
Edenbrook Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 39,899 Added 1.36% |
$355,500
$8.91 p/Share
|
Apr 06
2020 |
|
ALL
|
John E Dugenske |
SELL
Payment of exercise price or tax liability
|
Direct | 21,764 Reduced 31.9% |
$1,870,833
$85.96 p/Share
|
Apr 05
2020 |
|
ALL
|
John E Dugenske |
BUY
Exercise of conversion of derivative security
|
Direct | 49,128 Added 41.86% |
-
|
Apr 05
2020 |
|
ACN
|
Richard P Clark
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 140 Added 1.4% |
$21,490
$153.5 p/Share
|
Apr 05
2020 |
|
ACN
|
James O Etheredge
Chief Exec-North America |
BUY
Grant, award, or other acquisition
|
Direct | 159 Added 1.16% |
$24,406
$153.5 p/Share
|
Apr 05
2020 |
|
ACN
|
Kathleen R Mc Clure
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 159 Added 0.65% |
$24,406
$153.5 p/Share
|
Apr 05
2020 |
|
ACN
|
Jean Marc Ollagnier
CEO EMEA |
BUY
Grant, award, or other acquisition
|
Direct | 80 Added 0.04% |
$12,280
$153.5 p/Share
|
Apr 05
2020 |
|
ACN
|
Ellyn Shook
Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct | 159 Added 0.6% |
$24,406
$153.5 p/Share
|
Apr 05
2020 |
|
ACN
|
Julie Spellman Sweet
Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 204 Added 1.58% |
$31,314
$153.5 p/Share
|
Apr 05
2020 |
|
ACN
|
Joel Unruch
General Counsel/Corp Secretary |
BUY
Grant, award, or other acquisition
|
Direct | 131 Added 0.53% |
$20,108
$153.5 p/Share
|
Apr 05
2020 |